Paratek Pharmaceuticals Inc (PRTK)
Market Closed
20 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
2. 23
+0.04
+1.8265%
$
127.83M Market Cap
- P/E Ratio
31.97% Div Yield
4.48M Volume
- Eps
$ 2.19
Previous Close Want to track PRTK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Paratek Pharmaceuticals Inc (PRTK) Statistics
Valuation metrics
Market Cap 127.83M
Enterprise value 351.99M
Trailing P/E (ttm) -1.91
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 0.85
Price/Book (mrq) -0.71
Enterprise Value/Revenue 2.33
Enterprise Value/EBITDA -7.84
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 1.29
52-Week high 3.65
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Oct 2014
Ex-Dividend Date 31 Oct 2014
Last split factor 1:12
Last split Date 31 Oct 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.42%
Operating margin -0.31%
Operational effectiveness
Return on assets -0.37%
Return on equity 0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.77
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.63
Total debt (mrq) -
Total Debt/Equity (mrq) -1.51
Current ratio (mrq) 3.66%
Book value per share (mrq) -3.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
